When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Neuren Pharmaceuticals Ltd (ASX:NEU) CEO Jon Pilcher speaks withProactive following the news that its North America partner AcadiaPharmaceuticals has received US Food and Drug Administration approvalof DAYBUE™ (trofinetide) for the treatment of Rett syndrome in adultand pediatric patients. Acadia expects DAYBUE to be available by theend of April 2023.